AaronPatrickTansyMD
Neurology • South Plainfield, NJNeuroimaging, Vascular Neurology, Neurodegenerative
Sr. Medical Director, Clinical Development PTC Therapeutics, Inc.
Dr. Tansy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
100 Corporate Court
South Plainfield, NJ 07080
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Vascular Neurology, 2012 - 2013
New York Presbyterian Hospital (Columbia Campus)Residency, Neurology, 2006 - 2009- New York Presbyterian Hospital (Columbia Campus)Residency, Neurology, 2005 - 2008
The MetroHealth System/Case Western Reserve UniversityInternship, Internal Medicine, 2005 - 2006
Case Western Reserve University School of MedicineClass of 2005
Certifications & Licensure
NY State Medical License 2006 - 2026- American Board of Psychiatry and Neurology Neurology
- American Board of Psychiatry and Neurology Vascular Neurology
Clinical Trials
- Study to Assess the Effects of PTC857 Treatment in Participants With Amyotrophic Lateral Sclerosis ALS Start of enrollment: 2022 May 15
- A Long-Term Safety Study of PTC923 in Participants With Phenylketonuria Start of enrollment: 2022 Feb 14
- A Study of PTC923 in Participants With Phenylketonuria Start of enrollment: 2021 Sep 30
- Join now to see all
Publications & Presentations
PubMed
- 12 citationsDefining responders to therapies by a statistical modeling approach applied to randomized clinical trial dataFrancesca Bovis, Luca Carmisciano, Alessio Signori, Matteo Pardini, Joshua R. Steinerman
BMC Medicine. 2019-06-18 - 67 citationsA functional MRI study of preparatory signals for spatial location and objects.Maurizio Corbetta, Aaron P. Tansy, Christine M. Stanley, Serguei V. Astafiev, Abraham Z. Snyder
Neuropsychologia. 2005-01-01 - 27 citationsA randomized, placebo-controlled phase 2 trial of laquinimod in primary progressive multiple sclerosisGavin Giovannoni, Volker Knappertz, Joshua R. Steinerman, Aaron P. Tansy, Thomas Li
Neurology. 2020-08-25
Professional Memberships
- Member
External Links
- PTC Therapeutics http://www.ptcbio.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
